Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体
The Mammalian Cells 单克隆 anti-PDCD1 (Pembrolizumab Biosimilar) antibody is suitable to detect PDCD1 (Pembrolizumab Biosimilar) in samples from 人. It has been validated for ELISA.
产品编号 ABIN7487773
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体 (ABIN7487773)
抗原
PDCD1 (Pembrolizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This PDCD1 (Pembrolizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Pembrolizumab Biosimilar - Anti-PD1 mAb
-
产品特性
- Antibody Type: IgG4
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4
-
-
anti-PDCD1 (Pembrolizumab Biosimilar) antibody
Research Grade 适用: 人 FACS, ELISA 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C for short term, -20°C for long term
-
-
- PDCD1 (Pembrolizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Pembrolizumab
Pembrolizumab is a humanized (from mouse) monoclonal antibody that binds to, and blocks PD-1 located on lymphocytes. It is an anticancer medication used in the treatment of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, urothelial cancer (cancer of the bladder and urinary tract) and renal cell carcinoma (kidney cancer).
抗原
-
You are here:
